The approval covers IV and subcutaneous pembrolizumab and raises the TMB-H threshold from 10 to 13 mutations/megabase.
The FDA granted accelerated approval to dostarlimab (Jemperli) on October 19, 2026, for adults with stage II/III locally ...
Erika Hamilton, MD, breaks down liver monitoring, diarrhea, creatinine shifts, and oral adherence with maintenance tucatinib ...
European survey reveals how oncology nurses manage complex multiple myeloma care amid time and resource constraints. Keeping pace with innovation requires nurses to balance a growing volume of ...
Among patients with bacillus Calmette-Guérin (BCG)–unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) who achieved a complete response (CR) with nogapendekin alfa ...
The University of Kansas Cancer Center The University of South Alabama, Mitchell Cancer Institute The University of Texas MD Anderson Cancer Center The Winthrop P. Rockefeller Cancer Institute at the ...
Rev. Diane Baldwin is manager of Oncology Navigation Programs at the University of South Alabama Mitchell Cancer Institute (MCI) where she is also appointed as Chaplain. She is a member of the Academy ...
OncologyLive: Caregiver Connection | Publications | Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results